Magyar Imre EASD Clinical Postgraduate Course

14 November, Thursday

13:30 – 14:00 Opening ceremony
Prof. Béla Merkely, Rector, Semmelweis University
Zsolt Nyitrai, the Prime Minister’s Commissioner
Prof. Bruce Wolffenbuttel, member of the EASD Postgraduate Education Subcommittee
Prof. Peter Kempler, President of the Hungarian Diabetes Association

14:00 – 16:00 Session 1
Chairpersons: Bruce Wolfenbuttel, Nanette Schloot

14:00 – 14:30 MODY – summary for the diabetologist. How to explain differences in prevalence data - Zsolt Gaál, Hungary

14:30 – 15:00 Is there a role for personalized medicine in diabetes? – Bruce Wolfenbuttel, the Netherlands

15:00 – 15:30 Update on LADA – the clinician’s perspective - Nanette Schloot, Germany

15:30 – 16:00 Diabetes, bones and vitamin D - Péter Lakatos, Hungary

16:00 – 16:30 Coffee break

16:30 – 18:40 Workshops 1-3
(Each 60-min workshop is repeated once after a 10 minute break, participants attend 2 out of 3 workshops)
- Vitamin D for everybody? Zsuzsanna Putz, Hungary; Péter Lakatos, Hungary
- Self-monitoring of blood glucose in type 2 diabetic patients – why, when, how often? György Jermendy; Tibor Hidvégi, Hungary
- Personalized medicine in diabetes – is it really achievable in everyday clinical practice? Bruce Wolfenbuttel, the Netherlands; Zsolt Gaál, Hungary

19:00 Dinner



15 November, Friday

08:30 – 10:30 Session 2
Chairpersons: Peter Kempler, Karin Schara

08:30 – 09:00 The microbiome – a new therapeutical target? Tamás Halmos, Hungary

09:00 – 09:30 Autonomic neuropathy: impact on carbohydrate metabolism and therapeutical challenges - Péter Kempler, Hungary

09:30 – 10:00 Foot ulcers – the Cinderella of diabetic complications - Evgenya Patrakeeva, Russia

10:00 – 10:30 The diabetic foot – the surgeon’s perspective - Karin Schara, Slovenia

10:30 – 11:00 Coffee break

11:00 – 13:10 Workshops 4-6
(Each 60-min workshop is repeated once after a 10 minute break, participants attend 2 out of 3 workshops)
- The patient with pain in the leg – how to make the differential diagnosis? - Karin Schara, Slovenia; Evgenya Patrakeeva, Russia
- Approach to the patient with moderate elevation of serum creatinine - Leszek Czupryniak, Poland; Attila Gergő Molnár, Hungary
- Treating patients with type 1 diabetes from adolescence to senility – László Barkai, Ádám Tabák, Hungary

13:10 – 14:20 Group photo & Lunch

14:10 – 16:10 Session 3
Chairpersons: Martin Haluzik, Tamás Várkonyi

14:10 – 14:40 Gastrointestinal motility in diabetes – any connection between symptoms and findings? - Tamás Várkonyi, Hungary

14:40 – 15:10 Bariatric surgery – the diabetologist’s perspective - Martin Haluzik, Czech Republic

15:10 – 15:40 Balloon therapy – the gastroenterologist’s perspective - Péter Fuszek, Hungary

15:40 – 16:10 Oral health and diabetes - Dániel Végh, Hungary

16.10 – 16.30 Coffee break

16.30 – 18.40 Workshops 7-9
(Each 60-min workshop is repeated once after a 10 minute break, participants attend 2 out of 3 workshops)
- Non-pharmacological treatment of obesity - Martin Haluzik, Czech Republic; Péter Fuszek, Hungary
- Potential choices of treatment in type 2 diabetes after metformin: which drug for which patient? Angelo Avogaro, Italy; Tamás Várkonyi, Hungary
- GLP-1 analogues, basal insulins or both? - Francisco Javier Ampudia-Blasco, Spain; Csaba Lengyel, Hungary

20:00 – 22:00 Dinner



16 November, Saturday

08.30-10.00 Session 4
Chairpersons: Leszek Czupryniak, Francisco Javier Ampudia-Blasco

08:30 – 09:00 Polycystic ovarian syndrome, insulin resistance and metformin - Gyula Petrányi, Cyprus

09:00 – 09:30 Sport, illness and travel – challenges for the diabetologist and the diabetic patient - Leszek Czupryniak, Poland

09:30 – 10:00 Diabetes and depression - Boris Mankovsky, Ukraine

10:00 – 10:30 Glucose variability – diagnostic and therapeutical implications - Francisco Javier Ampudia-Blasco, Spain

10:30 – 11:00 Coffee break

11:00 – 12:30 Session 5
Chairpersons: Csaba Lengyel, György Jermendy

11.00 – 11:30 Epigenetics and diabetes – András Falus, Hungary

11.30 – 12:00 New insulins, new challenges – Csaba Lengyel, Hungary

12:00 – 12:30 Persistence to treatment with novel innovative antidiabetic drugs (DPP-4-inhibitors, SGLT-2-inhibitors and GLP-1-receptoragonists) in patients with type 2 diabetes – György Jermendy, Hungary

12.30 – 13:00 Impact of age on the risks of mortality, cardiovascular morbidity and dialysis in type 2 diabetic patients: a nationwide cohort study from Hungary – István Wittmann, Hungary

13.00-13.30 Light Lunch

13:30 – 15:00 Session 6
Chairpersons: Angeloa Avogaro, István Wittmann

13:30 – 14:00 Cardiovascular disease – the culprit of survival in diabetes mellitus? – Angelo Avogaro, Italy

14:00 – 14:30 Is there a common soil of cardiorenal complication in diabetes? – István Wittmann, Hungary

14:30 – 15:00 Pregnant women with diabetes – Ádám Tabák, Hungary

15.00 Closing Remarks and certificate distribution